StockData

Indaptus Therapeutics, Inc. (INDP) stock

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.29−0.03 (-0.90%)

Close on Nov 18, 2026Market cap $438.37MP/E –Yield –

Indaptus Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Indaptus Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$14.77M. For fiscal 2025 it was -$19.83M. The highest annual figure on record is -$3.60M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$19.83M–
FY2024Dec 31, 2024-$15.37M–
FY2023Dec 31, 2023-$16.38M–
FY2022Dec 31, 2022-$14.91M–
FY2021Dec 31, 2021-$7.73M–
FY2020Dec 31, 2020-$3.60M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.81M–
Q1 FY2026Mar 31, 2026-$2.16M–
Q4 FY2025Dec 31, 2025-$8.16M–
Q3 FY2025Sep 30, 2025-$2.65M–
Q2 FY2025Jun 30, 2025-$4.46M–
Q1 FY2025Mar 31, 2025-$4.57M–
Q4 FY2024Dec 31, 2024-$4.17M–
Q3 FY2024Sep 30, 2024-$3.14M–
Q2 FY2024Jun 30, 2024-$4.11M–
Q1 FY2024Mar 31, 2024-$3.94M–
Q4 FY2023Dec 31, 2023-$4.18M–
Q3 FY2023Sep 30, 2023-$4.25M–
Q2 FY2023Jun 30, 2023-$3.50M–
Q1 FY2023Mar 31, 2023-$4.46M–
Q4 FY2022Dec 31, 2022-$4.09M–
Q3 FY2022Sep 30, 2022-$3.55M–
Q2 FY2022Jun 30, 2022-$3.87M–
Q1 FY2022Mar 31, 2022-$3.40M–
Q4 FY2021Dec 31, 2021-$3.22M–
Q3 FY2021Sep 30, 2021-$3.37M–
Q2 FY2021Jun 30, 2021-$528.65K–
Q1 FY2021Mar 31, 2021-$613.98K–
Q4 FY2020Dec 31, 2020-$768.55K–
Q3 FY2020Sep 30, 2020-$1.55M–
Q2 FY2020Jun 30, 2020-$2.91M–

More Indaptus Therapeutics figures

See a number that looks wrong?